Hypera Lines Up Brazilian Semaglutide Launch Next Year

As Firm Sees ‘Aggressive’ Generic Competition In Its Domestic Market

 
• By Dave Wallace
  
Hypera is lining up an Ozempic rival for launch in Brazil next year (Shutterstock)

More from Generics

More from Business